Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 2
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Ecomectin 10 mg/ml V/MRP/07/1684 ECO Animal Health Europe Limited, Īrija QP54AA01 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ivermectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Battle, Hayward & Bower Ltd., Lielbritānija;Produlab Pharma b.v., Nīderlande;Divasa Farmavic S.A., Spānija
Date of authorisation/renewal: 09-Mar-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/07/1684-01 10 mg/ml 1 ABPE flakons, 50 ml -
V/MRP/07/1684-02 10 mg/ml 1 ABPE flakons, 200 ml -
V/MRP/07/1684-03 10 mg/ml 1 ABPE flakons, 500 ml -
V/MRP/07/1684-04 10 mg/ml 1 PET flakons, 250 ml -
V/MRP/07/1684-05 10 mg/ml 1 PET flakons, 50 ml -
V/MRP/07/1684-06 10 mg/ml 1 PET flakons, 500 ml -
Rilexine 200 - V/NRP/07/1702 Virbac S.A., Francija QJ51DB01 lactating cows Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Cefalexin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Virbac S.A., Francija;Haupt Pharma Latina s.r.l., Itālija
Date of authorisation/renewal: 14-Aug-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/07/1702-01 200 mg 4 Injektors, 1 deva -
V/NRP/07/1702-02 200 mg 12 Injektors, 1 deva -
Surricoxx 400 mg/ml V/DCP/21/0009 V.M.D. n.v., Beļģija QP51BX02 ducks; turkeys; chickens; Guinea fowl Vairāk

Medicinal product information

Pharmaceutical form: solution for use in drinking water
International name (active substance): Amprolium hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release V.M.D. n.v., Beļģija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0009-01 400 mg/ml 1 ABPE pudele, 100 ml -
V/DCP/21/0009-02 400 mg/ml 1 ABPE pudele, 1 l -
V/DCP/21/0009-03 400 mg/ml 1 ABPE konteiners, 5 l -
Pimotab 1.25 mg V/MRP/21/0003 CP-Pharma Handelsgesellschaft GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0003-01 1,25 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/MRP/21/0003-02 1,25 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/MRP/21/0003-03 1,25 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
Pimotab 2.5 mg V/MRP/21/0004 CP-Pharma Handelsgesellschaft GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0004-01 2,5 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/MRP/21/0004-02 2,5 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/MRP/21/0004-03 2,5 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
Pimotab 5 mg V/MRP/21/0005 CP-Pharma Handelsgesellschaft GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0005-01 5 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/MRP/21/0005-02 5 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/MRP/21/0005-03 5 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
Pimotab 10 mg V/MRP/21/0006 CP-Pharma Handelsgesellschaft GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0006-01 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/MRP/21/0006-02 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/MRP/21/0006-03 10 Al/OPA/Al/PVH blisteris, 10 tablete -
Benamix 6.25 mg/g V/DCP/25/0020 VIRBAC, Francija QC09AA07 cats Vairāk

Medicinal product information

Pharmaceutical form: premix for medicated feeding stuff
International name (active substance): Benazepril hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VIRBAC, Francija
Date of authorisation/renewal: 25-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (25-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0020-01 1 Kanna, 4,032 kg -
Pimotab 15 mg V/MRP/21/0007 CP-Pharma Handelsgesellschaft GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0007-01 15 mg 6 Al/OPA/Al/PVH blisteris, 5 tablete -
V/MRP/21/0007-02 15 mg 10 Al/OPA/Al/PVH blisteris, 5 tablete -
V/MRP/21/0007-03 15 mg 20 Al/OPA/Al/PVH blisteris, 5 tablete -
Mitex - V/DCP/15/0006 VetViva Richter GmbH , Austrija QS02CA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: ear drops and cutaneous suspension
International name (active substance): Miconazole nitrate, Prednisolone acetate, Polymyxin B sulphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VetViva Richter GmbH , Austrija
Date of authorisation/renewal: 30-Oct-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Jan-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (16-Jan-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0006-01 1 ZBPE pudelīte, 20 ml -
Pergoquin 1 mg V/DCP/19/0079 VetViva Richter GmbH , Austrija QN04BC02 horses Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Pergolide mesylate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraks (24-Aug-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraks (24-Aug-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (12-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0079-01 1 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0079-02 1 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0079-03 1 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0079-04 1 mg 15 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0079-05 1 mg 16 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0079-06 1 mg 20 Al/OPA/Al/PVH blisteris, 10 tablete [PDF] [PDF] [DOCX]
Exagon 400 mg/ml V/DCP/14/0001 VetViva Richter GmbH , Austrija QN51AA01 tortoises; guinea pigs; hamsters; birds; poultry; cattle; pigs; horses; mouses; rats; dogs; cats; rabbits; minks; pigeons; ponies; snakes; lizards; frogs; hares; polecats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Pentobarbital Sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VetViva Richter GmbH , Austrija
Date of authorisation/renewal: 31-Oct-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (07-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0001-01 400 mg/ml 1 Stikla flakons, 100 ml -
V/DCP/14/0001-02 400 mg/ml 5 Stikla flakons, 100 ml -
Bupaq 0.3 mg/ml V/MRP/18/0042 VetViva Richter GmbH , Austrija QN02AE01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Buprenorphine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VetViva Richter GmbH , Austrija
Date of authorisation/renewal: 28-Jun-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/18/0042-01 3 Stikla flakons, 2 ml -
V/MRP/18/0042-02 4 Stikla flakons, 2 ml -
V/MRP/18/0042-03 5 Stikla flakons, 2 ml -
V/MRP/18/0042-04 6 Stikla flakons, 2 ml -
V/MRP/18/0042-05 10 Stikla flakons, 2 ml -
Butagran Equi 200 mg/g V/DCP/12/0072 Dopharma Research B.V., Nīderlande QM01AA01 horses Vairāk

Medicinal product information

Pharmaceutical form: oral powder
International name (active substance): Phenylbutazone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Dopharma B.V., Nīderlande
Date of authorisation/renewal: 03-Jan-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (05-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (05-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (05-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/12/0072-01 200 mg/g 100 PET/LDPE/Al folijas/LDPE paciņa, 5 g -
V/DCP/12/0072-02 200 mg/g 20 PET/LDPE/Al folijas/LDPE paciņa, 5 g -
V/DCP/12/0072-03 200 mg/g 100 Al folijas/LDPE/papīra/LDPE paciņa, 5 g -
V/DCP/12/0072-04 200 mg/g 20 Al folijas/LDPE/papīra/LDPE paciņa, 5 g -
Synulox LC - V/MRP/98/0770 Zoetis Belgium S.A., Beļģija QJ51RV01 lactating cows Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Amoxicillin trihydrate, Prednisolone acetate, Potassium clavulanate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Haupt Pharma Latina S.R.L., Itālija
Date of authorisation/renewal: 13-Jun-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (31-May-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (31-May-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (25-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/98/0770-01 24 Injektors, 1 deva -
V/MRP/98/0770-02 300 Injektors, 1 deva -
V/MRP/98/0770-05 12 Injektors, 1 deva -
Enrobioflox 10% 100 mg/ml V/NRP/96/0284 Vetoquinol Biowet Sp. z o.o., Polija QJ01MA90 pigs; calves; chickens Vairāk

Medicinal product information

Pharmaceutical form: solution for oral use
International name (active substance): Enrofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol Biowet Sp. z. o. o., Polija
Date of authorisation/renewal: 04-Jul-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 230818LI (23-Jul-2018)
Labelling text: [PDF] 230718M (23-Jul-2018)
Summary of product characteristics: [PDF] 230718ZA (23-Jul-2018)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0284-01 100 mg/ml 1 Stikla flakons, 50 ml -
V/NRP/96/0284-02 100 mg/ml 1 Stikla flakons, 1000 ml -
Fipron 268 mg V/MRP/16/0023 Bioveta, a.s., Čehija QP53AX15 large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 01-Feb-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] 300117LI (01-Feb-2017)
Labelling text: [PDF] 300117M (01-Feb-2017)
Summary of product characteristics: [PDF] 300117ZA (01-Feb-2017)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/16/0023-01 268 mg/deva 1 Polietilēna tūbiņa, 1 deva -
V/MRP/16/0023-02 268 mg/deva 3 Polietilēna tūbiņa, 1 deva -
V/MRP/16/0023-03 268 mg/deva 25 Polietilēna tūbiņa, 1 deva -
Fipron 50 mg V/MRP/16/0020 Bioveta, a.s., Čehija QP53AX15 cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 01-Feb-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] 300117LI (01-Feb-2017)
Labelling text: [PDF] 300117M (01-Feb-2017)
Summary of product characteristics: [PDF] 300117ZA (01-Feb-2017)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/16/0020-01 50 mg/deva 1 Polietilēna tūbiņa, 1 deva -
V/MRP/16/0020-02 50 mg/deva 3 Polietilēna tūbiņa, 1 deva -
V/MRP/16/0020-03 50 mg/deva 25 Polietilēna tūbiņa, 1 deva -
TAbic IB VAR206 - V/MRP/19/0082 PHIBRO ANIMAL HEALTH (POLAND) Sp. z o.o., Polija QI01AD07 chickens Vairāk

Medicinal product information

Pharmaceutical form: effervescent tablets
International name (active substance): Live attenuated Avian Infectious Bronchitis Virus, variant strain 2-06
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Synoptis Industrial Sp. z o.o., Polija
Date of authorisation/renewal: 27-Oct-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Dec-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Dec-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Dec-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/19/0082-01 1 PVH/PVDH blisteris, 500 deva -
V/MRP/19/0082-02 2 PVH/PVDH blisteris, 500 deva -
V/MRP/19/0082-03 1 PVH/PVDH blisteris, 1000 deva -
V/MRP/19/0082-04 2 PVH/PVDH blisteris, 1000 deva -
V/MRP/19/0082-05 1 PVH/PVDH blisteris, 2000 deva -
V/MRP/19/0082-06 2 PVH/PVDH blisteris, 2000 deva -
V/MRP/19/0082-07 1 PVH/PVDH blisteris, 5000 deva -
V/MRP/19/0082-08 2 PVH/PVDH blisteris, 5000 deva -
V/MRP/19/0082-09 1 PVH/PVDH blisteris, 10000 deva -
V/MRP/19/0082-10 2 PVH/PVDH blisteris, 10000 deva -
V/MRP/19/0082-11 1 PVH/PVDH blisteris, 2500 deva -
V/MRP/19/0082-12 2 PVH/PVDH blisteris, 2500 deva -
V/MRP/19/0082-13 1 PVH/PVDH blisteris, 1500 deva -
V/MRP/19/0082-14 2 PVH/PVDH blisteris, 1500 deva -
V/MRP/19/0082-15 1 PVH/PVDH blisteris, 3000 deva -
V/MRP/19/0082-16 2 PVH/PVDH blisteris, 3000 deva -
V/MRP/19/0082-17 1 PVH/PVDH blisteris, 3500 deva -
V/MRP/19/0082-18 2 PVH/PVDH blisteris, 3500 deva -
V/MRP/19/0082-19 1 PVH/PVDH blisteris, 4000 deva -
V/MRP/19/0082-20 2 PVH/PVDH blisteris, 4000 deva -
Furosoral vet 10 mg V/MRP/14/0062 Le Vet Beheer B.V., Nīderlande QC03CA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Furosemide
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;Artesan Pharma, Vācija;GENERA Inc., Horvātija
Date of authorisation/renewal: 01-Aug-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 20032024LI (20-Mar-2024)
Labelling text: [DOCX] 20032024M (20-Mar-2024)
Summary of product characteristics: [DOCX] 20032024ZA (20-Mar-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/14/0062-01 10 mg 1 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0062-02 10 mg 2 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0062-03 10 mg 3 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0062-04 10 mg 4 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0062-05 10 mg 5 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0062-06 10 mg 6 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0062-07 10 mg 7 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0062-08 10 mg 8 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0062-09 10 mg 9 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0062-10 10 mg 10 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0062-11 10 mg 25 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0062-12 10 mg 50 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0062-13 10 mg 100 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0062-14 10 mg 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/MRP/14/0062-15 10 mg 2 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/MRP/14/0062-16 10 mg 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/MRP/14/0062-17 10 mg 4 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/MRP/14/0062-18 10 mg 5 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/MRP/14/0062-19 10 mg 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/MRP/14/0062-20 10 mg 7 PVDH/PE/PVH/Al blisteris, 10 tablete -

3082 records

© Food and veterinary service · 2026 Cookies policy